BMLL — Bio Medica Laboratories Share Price
Last trade - 00:00- IN₹1.54bn
- IN₹1.69bn
- IN₹381.95m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 10.46 | ||
| Price to Tang. Book | 10.46 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.03 | ||
| EV to EBITDA | 11 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 64.94% | ||
| Return on Equity | 66.48% | ||
| Operating Margin | 37.61% | ||
Financial Summary
| Year End 31st Mar | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 129.26 | 212.25 | 162.28 | 152.49 | 381.95 | n/a | n/a | 31.11% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +34.1 | -43.38 | +649.24 | +292 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Bio Medica Laboratories Ltd is engaged in the manufacturing of pharmaceutical parenteral formulations. The Company manufactures variety of products, comprising ethical drugs, generic drugs and over the-counter drugs (OTC) in the form of injectables namely Liquid injections and dry powder injections. These injectables are available in both single dose and multi dose forms, catering both human and veterinary needs. Its products address a range of medical needs and preferences both domestically as well as exported through merchant exporter. It offers a total of 58 products. Its products include 100 ml Amikacin Sulphate IP Injection, Vitamin B12, D3 & Calcium Gluconolactobionate Injection, 2ml Amikacin Sulphate Injection, Buprenorphine Injection, and 30 ml Amikacin Sulphate Injection. Buprenorphine injection is used as a short-term treatment to relieve severe pain in people who need an opioid pain medication and who cannot be treated with other pain medications.
Directors
- Last Annual
- March 31st, 2025
- Last Interim
- January 1st, 1970
- Incorporated
- August 14th, 2015
- Public Since
- May 29th, 2026
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 12,575,001
- Address
- Plot-254, Sector-F Sanwer Road, INDORE, 452015
- Web
- https://biomedica.co.in
- Phone
- +91 7314102751
- Auditors
Similar to BMLL
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
As of Today at 19:36 UTC, shares in Bio Medica Laboratories are trading at IN₹122.50. This share price information is delayed by 15 minutes.
Shares in Bio Medica Laboratories last closed at IN₹122.50 and the price had moved by over the past 365 days. In terms of relative price strength the Bio Medica Laboratories share price has matched the S&P BSE 100 Index by over the past year.
There is no consensus recommendation for this security.
Find out moreBio Medica Laboratories does not currently pay a dividend.
Bio Medica Laboratories does not currently pay a dividend.
Bio Medica Laboratories does not currently pay a dividend.
To buy shares in Bio Medica Laboratories you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹122.50, shares in Bio Medica Laboratories had a market capitalisation of IN₹1.54bn.
Here are the trading details for Bio Medica Laboratories:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: BMLL
Based on an overall assessment of its quality, value and momentum Bio Medica Laboratories is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bio Medica Laboratories. Over the past six months, its share price has matched the S&P BSE 100 Index by .
As of the last closing price of IN₹122.50, shares in Bio Medica Laboratories were trading +7.72% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Bio Medica Laboratories PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹122.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Bio Medica Laboratories' directors